We Can Medicines Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	3,269	3,123	3,303	2,794	2,667
Revenue Growth (YoY)	4.69%	-5.45%	18.20%	4.77%	-
Cost of Revenue	2,173	2,099	2,191	1,878	1,798
Gross Profit	1,097	1,023	1,112	916.55	868.45
Selling, General & Admin	1,147	1,002	990.45	886.13	833.87
Operating Expenses	1,147	999.52	994.39	886.22	833.81
Operating Income	-50.01	23.94	117.2	30.33	34.64
Interest Expense	-27.43	-23.46	-19.09	-14.43	-13.26
Interest & Investment Income	1.25	0.62	0.24	0.05	0.06
Currency Exchange Gain (Loss)	0.01	-0.01	1.64	-0.26	-
Other Non Operating Income (Expenses)	31.56	25.28	31.91	24.76	21.5
EBT Excluding Unusual Items	-44.62	26.37	131.9	40.45	42.94
Gain (Loss) on Sale of Investments	0.37	-	0.11	0.19	-
Gain (Loss) on Sale of Assets	-0.14	-2.77	-7.2	-1.85	-1.1
Asset Writedown	-4.4	-2	-3.68	-	0.86
Other Unusual Items	0.5	-	-	-	-
Pretax Income	-48.29	21.6	121.13	38.79	42.71
Income Tax Expense	-1.12	6.8	21.08	-	-
Net Income	-47.18	14.8	100.05	38.79	42.71
Net Income to Common	-47.18	14.8	100.05	38.79	42.71
Net Income Growth	-	-85.20%	157.91%	-9.16%	-
Shares Outstanding (Basic)	43	40	40	40	32
Shares Outstanding (Diluted)	43	42	42	40	32
Shares Change (YoY)	2.86%	1.26%	4.31%	24.84%	-
EPS (Basic)	-1.09	0.37	2.50	0.97	1.33
EPS (Diluted)	-1.09	0.35	2.40	0.97	1.33
EPS Growth	-	-85.42%	147.46%	-27.08%	-
Free Cash Flow	196.73	47.29	224.13	117.58	21.05
Free Cash Flow Per Share	4.53	1.12	5.37	2.94	0.66
Dividend Per Share	-	0.270	-	-	-
Gross Margin	33.54%	32.77%	33.66%	32.80%	32.57%
Operating Margin	-1.53%	0.77%	3.55%	1.08%	1.30%
Profit Margin	-1.44%	0.47%	3.03%	1.39%	1.60%
Free Cash Flow Margin	6.02%	1.51%	6.79%	4.21%	0.79%
EBITDA	18.4	84.94	175.47	76.28	71.15
EBITDA Margin	0.56%	2.72%	5.31%	2.73%	2.67%
D&A For EBITDA	68.41	61	58.27	45.95	36.51
EBIT	-50.01	23.94	117.2	30.33	34.64
EBIT Margin	-1.53%	0.77%	3.55%	1.08%	1.30%
Effective Tax Rate	-	31.47%	17.40%	-	-
Advertising Expenses	8.16	-	903.85	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.